02415 MEDSCI
- 1.870
- -0.230-10.95%
MEDSCI News
MeisHealth's affiliated biopharmaceutical valley has reached a strategic cooperation agreement with Weigao Group.
Mei's Health (02415) issued an announcement that its subsidiary, Shanghai Chungu Biomedical Technology Co., Ltd. (Biological Valley) has officially reached a strategic cooperation with Weigh Group Co., Ltd. (Weigh Group) recently. Both parties will cooperate through the joint construction of multiple alliances such as the media cooperation promotion, park investment promotion, and industry sharing and exchange strategic services alliance, market acceleration service strategic alliance, scientific research and innovation alliance, and financial services innovation alliance. By stimulating more local innovation vitality, deeply promoting the influence of Weigh Park and Weigh Group's quality products, and helping Weigh Group's core competitiveness in the industry to continue to rise. The Chinese medical industry is right.
MedSci Healthcare Announces Strategic Partnership
Mei's Health (02415.HK) subsidiary Biovalley has reached a strategic cooperation with Weigao Group.
On July 19th, Health Industry Mesooon Inc. (02415.HK) announced that its subsidiary Shanghai Chungu Biomedical Technology Co., Ltd. ("Chungu Biomedical") has officially reached a strategic cooperation with Weigao Group Co., Ltd. ("Weigao Group"). The two parties will cooperate in multiple alliances, such as media promotion, park investment promotion, and strategic service alliances for industry sharing and exchange, market acceleration services, scientific research and innovation alliances, and financial services and innovation alliances. They will work together to stimulate more local innovation energy, deepen the influence of Weigao Park and the high-quality products of Weigao Group, and help Weigao Group's core competencies in the industry.
Express News | MedSci Healthcare - Entry of Strategic Cooperation Between Valley Bio and Weigao Holding
Lacklustre Performance Is Driving MedSci Healthcare Holdings Limited's (HKG:2415) 31% Price Drop
MedSci Healthcare Co-CEO Steps Down; Successor Named
MedSci Healthcare Unveils Board Structure
Meis Health (02415.HK): Wang Shuai has been appointed as the Joint Chief Executive Officer of the Group.
On July 16th, Gelonhui announced that starting from July 16th, 2024: (i) Fan Jie, executive director and joint CEO of the group will no longer serve as joint CEO of the group; (ii) Wang Shuai, executive director, has been appointed as joint CEO of the group; and (iii) Cheng Liang has been appointed as the group's chief operating officer.
Express News | MedSci Healthcare - Wang Shuai Appointed Co-Chief Executive Officer
Express News | MedSci Healthcare - Fan Jie Has Ceased to Be Co-Chief Executive Officer of Group
MedSci Healthcare Buys Back Shares Under Incentive Scheme
Meihs-kang (02415): The trustee purchased a total of 100,000 shares under the stock incentive plan.
Mason Health (02415) announced on the Zhitong Financial APP that on June 25, 2024, the trustee purchased a total of 100,000 shares from the Hong Kong Stock Exchange for the plan. The average unit cost per share is about HKD 1.87.
MedSci Healthcare Holdings' Subsidiary Wins Bid for Large-Scale Study of Psoriasis Treatment
Meisai Health (02415.HK) won the bid for the large real-world research project on China's moderate to severe plaque silver disease.
On June 25th, Gralon Healthcare (02415.HK) announced that its subsidiary, Shanghai Meis Medical Technology Co., Ltd., recently won the bid for the project "The efficacy and safety of the application of secukinumab injection in Chinese moderate and severe plaque psoriasis patients: a prospective, multicenter, non-interventional large-scale real-world study" of Chongqing Zhixiang Jintai Biopharmaceutical Co., Ltd. The project amount is approximately RMB 21 million. With the support of more than ten years of internet plus-related doctor platforms, the Group links doctors, patients, and pharmaceutical companies with big data and AI technology to provide digital solutions that empower the industry.
Express News | MedSci Healthcare - Unit Awarded Bid for Project With Value of RMB21 Mln
Express News | MedSci Healthcare - Bidding of Large-Scale Real-World- Study on Moderate-to-Severe Psoriasis in China
MEDSCI: 2023 ANNUAL REPORT
Medsci Healthcare Rebounds to 2023 Profit
Mace Health (02415) announced 2023 annual results, net profit of 55.42 million yuan
Mace Health (02415) announced results for the year ended December 31, 2023, with revenue of 349 million yuan (...
MEDSCI: ANNUAL RESULTS ANNOUNCEMENTFOR THE YEAR ENDED 31 DECEMBER 2023
Analysis
Price Target
No Data
